P.020 Avelumab in newly diagnosed glioblastoma multiforme-the SEJ study
نویسندگان
چکیده
منابع مشابه
Longitudinal MRSI study in newly diagnosed Glioblastoma Multiforme
Introduction Glioblastoma Multiforme (GBM) is the most common and the most malignant type of glioma. Despite the advances in multimodality treatments that combine surgery, radiation and chemotherapy, patients with GBM have a limited prognosis, with a median survival of one year. The standard criteria for assessing tumor progression and response to therapy are based upon changes in cross section...
متن کاملCurrent Advances in Radiotherapy for Newly Diagnosed Glioblastoma Multiforme
Copyright: © 2014 Okonogi N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
متن کاملComparative Study of Adjuvant Temozolomide Six Cycles Versus Extended 12 Cycles in Newly Diagnosed Glioblastoma Multiforme.
INTRODUCTION Studies have shown promising survival with the use of Extended Temozolomide (E-TMZ) as compared to Conventional six cycles of Temozolomide (C-TMZ) in malignant gliomas; however, the reports are mostly limited to retrospective studies with significant bias. AIM This study assesses the impact of six versus 12 cycles of adjuvant Temozolomide (TMZ) on Overall Survival (OS) in newly d...
متن کاملA pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiforme.
PURPOSE To define the maximum tolerated dose (MTD) of lenalidomide, an analogue of thalidomide with enhanced immunomodulatory and antiangiogenic properties and a more favorable toxicity profile, in patients with newly diagnosed glioblastoma multiforme (GBM) when given concurrently with radiotherapy. PATIENTS AND METHODS Patients with newly diagnosed GBM received radiotherapy concurrently with...
متن کاملThe timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme
There are few and conflicting studies on the optimal timing of initial cranial radiation in the treatment of glioblastoma multiforme (GBM) but none of them have addressed this issue in the elderly population. We used the linked Surveillance, Epidemiology, and End Results (SEER) Medicare database to investigate whether the time interval from surgery to initiation of radiation is a significant pr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
سال: 2019
ISSN: 0317-1671,2057-0155
DOI: 10.1017/cjn.2019.120